User profiles for Peter Öhman
![]() | Peter ÖhmanProfessor of Business Administration, Mid Sweden University Verified email at miun.se Cited by 4055 |
Perspektiv på revision: tankemönster, förväntningsgap och dilemman
P Öhman - 2007 - diva-portal.org
Auditing is an important activity in today’s society and is characterised by several dilemmas.
The assumption underlying this thesis is that auditing is influenced in prac-tice by the …
The assumption underlying this thesis is that auditing is influenced in prac-tice by the …
Swedish auditors' view of auditing: Doing things right versus doing the right things
P Öhman, E Häckner, AM Jansson… - European accounting …, 2006 - Taylor & Francis
This paper aims to describe and analyse the thought patterns of Swedish auditors with
regard to the way in which they audit information provided by listed companies, and possible …
regard to the way in which they audit information provided by listed companies, and possible …
[HTML][HTML] Effects of once-weekly exenatide on cardiovascular outcomes in type 2 diabetes
…, AP Maggioni, SP Marso, P Öhman… - … England Journal of …, 2017 - Mass Medical Soc
Background The cardiovascular effects of adding once-weekly treatment with exenatide to
usual care in patients with type 2 diabetes are unknown. Methods We randomly assigned …
usual care in patients with type 2 diabetes are unknown. Methods We randomly assigned …
Auditors' time pressure: Does ethical culture support audit quality?
J Svanberg, P Öhman - Managerial auditing journal, 2013 - emerald.com
Purpose – The purpose of this paper is to address the impact of ethical culture on audit quality
under conditions of time budget pressure. The study also tests the relationship between …
under conditions of time budget pressure. The study also tests the relationship between …
Debt financing and firm performance: an empirical study based on Swedish data
D Yazdanfar, P Öhman - The Journal of Risk Finance, 2015 - emerald.com
Purpose – The purpose of this study is to examine the relationship between debt level and
performance among small and medium-sized enterprises (SMEs). Design/methodology/…
performance among small and medium-sized enterprises (SMEs). Design/methodology/…
The impact of cash conversion cycle on firm profitability: An empirical study based on Swedish data
D Yazdanfar, P Öhman - International Journal of Managerial Finance, 2014 - emerald.com
… Peter Öhman (Department of Business, Economics and Law, Centre for Research on
Economic Relations, Mid Sweden University, Sundsvall, Sweden) … and Öhman, P. (2014) …
Economic Relations, Mid Sweden University, Sundsvall, Sweden) … and Öhman, P. (2014) …
A practitioner's guide to light weight software process assessment and improvement planning
…, M Ivarsson, T Gorschek, P Öhman - Journal of Systems and …, 2008 - Elsevier
Software process improvement (SPI) is challenging, particularly for small and medium sized
enterprises. Most existing SPI frameworks are either too expensive to deploy, or do not take …
enterprises. Most existing SPI frameworks are either too expensive to deploy, or do not take …
Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a meta-analysis
…, N Iqbal, AP Maggioni, P Öhman… - The lancet Diabetes & …, 2018 - thelancet.com
Background Glucagon-like peptide-1 (GLP-1) receptor agonists are effective glucose-lowering
drugs. Findings from cardiovascular outcome trials showed cardiovascular safety of GLP-…
drugs. Findings from cardiovascular outcome trials showed cardiovascular safety of GLP-…
Exenatide once weekly plus dapagliflozin once daily versus exenatide or dapagliflozin alone in patients with type 2 diabetes inadequately controlled with metformin …
…, E Hardy, A Ahmed, F Dong, P Öhman… - The lancet Diabetes & …, 2016 - thelancet.com
Background Glucagon-like peptide-1 (GLP-1) receptor agonists and sodium-glucose co-transporter-2
(SGLT2) inhibitors reduce glycaemia and weight, and improve cardiovascular risk …
(SGLT2) inhibitors reduce glycaemia and weight, and improve cardiovascular risk …
Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus
…, J Davidson, B Hirshberg, P Ohman… - … England Journal of …, 2013 - Mass Medical Soc
Background The cardiovascular safety and efficacy of many current antihyperglycemic agents,
including saxagliptin, a dipeptidyl peptidase 4 (DPP-4) inhibitor, are unclear. Methods We …
including saxagliptin, a dipeptidyl peptidase 4 (DPP-4) inhibitor, are unclear. Methods We …